Literature DB >> 10708003

Acute adenolymphangitis due to bancroftian filariasis in Rufiji district, south east Tanzania.

D B Gasarasi1, Z G Premji, P G Mujinja, R Mpembeni.   

Abstract

A longitudinal prospective surveillance for acute adenolymphagitis (ADL) was carried out in three villages in Rufiji district. A sample population of 3000 individuals aged 10 years and above was monitored fortnightly for a period of 12 months. The annual incidence of ADL was found to be 33 per 1000 population and was significantly higher in males than females (52.7/1000 and 18.7/1000 respectively). ADL episodes were more frequent in the age group of 40 years and above. Individuals with chronic manifestations seemed to be more vulnerable to ADL attacks with 62.2% of the total episodes occurring in this group. Furthermore, individuals with lymphoedema experienced more frequent acute episodes compared to those with hydrocele and 'normal exposed'. ADL episodes ranged from one to five per annum and the majority of the affected (60.4%) experienced a single episode. The average duration of an ADL episode was 8.6 days and in 72.5% of the episodes the affected individuals were incapacitated and unable to do their normal activities for an average duration of 3.7 days. The physical incapacitation associated with ADL episodes emphasizes the significance of lymphatic filariasis as a major public health problem of substantial socio-economic consequences.

Entities:  

Mesh:

Year:  2000        PMID: 10708003     DOI: 10.1016/s0001-706x(99)00090-x

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  19 in total

1.  Investing in justice: ethics, evidence, and the eradication investment cases for lymphatic filariasis and onchocerciasis.

Authors:  Theodore C Bailey; Maria W Merritt; Fabrizio Tediosi
Journal:  Am J Public Health       Date:  2015-02-25       Impact factor: 9.308

2.  A refined and updated health impact assessment of the Global Programme to Eliminate Lymphatic Filariasis (2000-2020).

Authors:  Hugo C Turner; Eric A Ottesen; Mark H Bradley
Journal:  Parasit Vectors       Date:  2022-05-28       Impact factor: 4.047

3.  The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007).

Authors:  Brian K Chu; Pamela J Hooper; Mark H Bradley; Deborah A McFarland; Eric A Ottesen
Journal:  PLoS Negl Trop Dis       Date:  2010-06-01

4.  Clustering of under-five mortality in Rufiji Health and Demographic Surveillance System in rural Tanzania.

Authors:  Josephine Shabani; Angelina M Lutambi; Victoria Mwakalinga; Honorati Masanja
Journal:  Glob Health Action       Date:  2010-08-30       Impact factor: 2.640

5.  Community-based survey of podoconiosis in Bedele Zuria woreda, west Ethiopia.

Authors:  Fasil Tekola Ayele; Getahun Alemu; Gail Davey; Christel Ahrens
Journal:  Int Health       Date:  2013-06       Impact factor: 2.473

6.  Reduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea.

Authors:  Daniel J Tisch; Neal D E Alexander; Benson Kiniboro; Henry Dagoro; Peter M Siba; Moses J Bockarie; Michael P Alpers; James W Kazura
Journal:  PLoS Negl Trop Dis       Date:  2011-07-12

7.  Burden of podoconiosis in poor rural communities in Gulliso woreda, West Ethiopia.

Authors:  Getahun Alemu; Fasil Tekola Ayele; Takele Daniel; Christel Ahrens; Gail Davey
Journal:  PLoS Negl Trop Dis       Date:  2011-06-07

Review 8.  Neglected tropical diseases and the millennium development goals: why the "other diseases" matter: reality versus rhetoric.

Authors:  David H Molyneux; Mwele N Malecela
Journal:  Parasit Vectors       Date:  2011-12-13       Impact factor: 3.876

9.  Epidemiology of episodic adenolymphangitis: a longitudinal prospective surveillance among a rural community endemic for bancroftian filariasis in coastal Orissa, India.

Authors:  Bontha V Babu; Abhay N Nayak; Kalpataru Dhal
Journal:  BMC Public Health       Date:  2005-05-19       Impact factor: 3.295

10.  Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature.

Authors:  David G Addiss; Molly A Brady
Journal:  Filaria J       Date:  2007-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.